BMK headline results beat expectations through regaining an upper hand in tussles with Salmosan generics and stronger than expected H2 results from Animal Health and Technical Publishing divisions.
05 Feb 2016
Feeding sustainable growth ambitions
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Feeding sustainable growth ambitions
Benchmark Holdings Plc (BMK:LON) | 43.2 0.1 0.6% | Mkt Cap: 319.9m
- Published:
05 Feb 2016 -
Author:
Robin Campbell -
Pages:
23
BMK headline results beat expectations through regaining an upper hand in tussles with Salmosan generics and stronger than expected H2 results from Animal Health and Technical Publishing divisions.